paclitaxel has been researched along with Lymphoma, Follicular in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, D; Masuda, T; Nakashima, Y; Narazaki, T; Ogawa, Y; Ohshima, K; Shiratsuchi, M; Takamatsu, A; Tsuda, M; Tsukamoto, Y | 1 |
| Allman, R; Errington, RJ; Smith, PJ | 1 |
| Cabanillas, F; Hagemeister, FB; McLaughlin, P; Pro, B; Rodriguez, MA; Romaguera, J; Tiongson, LP; Younes, A | 1 |
| Andreeff, M; Cabanillas, F; Consoli, U; Huh, Y; McLaughlin, P; Rodriguez, A; Sarris, A; Starry, S; Younes, A | 1 |
| Bassan, R; Di Gaetano, N; Erba, E; Golay, J; Introna, M; Rambaldi, A; Xiao, Y | 1 |
2 trial(s) available for paclitaxel and Lymphoma, Follicular
| Article | Year |
|---|---|
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome; Vidarabine | 2006 |
A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Combined Modality Therapy; Female; Growth Inhibitors; Hematopoiesis; Humans; Immunologic Factors; Interleukin-3; Lymphoma, Follicular; Male; Middle Aged; Neoplastic Stem Cells; Neutrophils; Paclitaxel; Pilot Projects; Treatment Outcome | 1996 |
3 other study(ies) available for paclitaxel and Lymphoma, Follicular
| Article | Year |
|---|---|
Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Female; Humans; Lymphoma, Follicular; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel | 2019 |
Delayed expression of apoptosis in human lymphoma cells undergoing low-dose taxol-induced mitotic stress.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, Follicular; Mitosis; Paclitaxel; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Blotting, Northern; Cisplatin; Complement System Proteins; Cytotoxicity Tests, Immunologic; Doxorubicin; Drug Synergism; Fluorescent Antibody Technique; Humans; Idarubicin; In Situ Nick-End Labeling; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Paclitaxel; Rituximab; Tumor Cells, Cultured; Vidarabine | 2001 |